Pharma major Lupin announced the launch of a chatbot named ‘ANYA’ specially designed to provide medically verified information for health-related queries. It’s a made in India for India initiative aimed at answering patient queries related to ailments.
One of the India’s leading pharma company Lupin Laboratories Ltd has released a chat-bot named ANYA, which has been built and programmed to provide medically verified information for health-related queries.
It is said that it is first bot of its kind launched in India for disease awareness, ANYA has been designed to be intelligent and patient-friendly. The chat-bot has been created to answer patient queries about ailments.
ANYA has been specially designed to help patients with health-related concerns as part of their disease management.
The first therapy area ANYA will provide most reliable and accurate information to users is diabetes, which is one of the most common lifestyle conditions in India.
Lupin IRF president Rajeev Sibal said: “Chatbot as a technology has enormous potential to aid in medical assistance and to support in building awareness and breaking myths associated with various therapies.
“Chatbot as a technology has enormous potential to aid in medical assistance.”
“We are taking the first step to offer this AI-based chatbot for patients and health-givers and we believe this will be a game-changer in the field of disease management in the future.
“This will also be a significant step in providing better access in rural markets as we adopt and launch digital healthcare platforms for better outreach.”
ANYA is intended as a disease-management partner, and has been designed to address all patient queries and ensures their health correspondence continues.
Its main prupose is to help patients partnering with doctors to manage health related issues. It also offers a platform for patients to gain access to medically verified information for their questions at any time.
Furthermore, ANYA is aimed at being a best authorised partner for doctors in resolving patient problems and providing medically accurate information.
According to a recent research, India is estimated to have had 72 million cases of diabetes last year and the number is expected to almost double to 134 million by 2025.